Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Stephanie Vairy
CTL019 (Tisagenlecleucel): CAR-T Therapy for Relapsed and Refractory B-Cell Acute Lymphoblastic Leukemia
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Related publications
CAR-T Cells and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
Immunotherapy
Oncology
Allergy
Immunology
Role of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia
Memo - Magazine of European Medical Oncology
Oncology
Hematology
Cd19-Directed Car T Cell Therapy (Ctl019) for Relapsed/Refractory Diffuse Large B-Cell and Follicular Lymphomas: Four Year Outcomes
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Efficacy and Safety of Humanized Anti-Cd19-Car-T Therapy Following Intensive Lymphodepleting Chemotherapy for Refractory/Relapsed B Acute Lymphoblastic Leukaemia
British Journal of Haematology
Hematology
Potent Anti-Leukemia Activities of Humanized CD19-targeted CAR-T Cells in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
American Journal of Hematology
Hematology
CAR T Cells for Acute Lymphoblastic Leukemia
American Journal of Hematology
Hematology
Bortezomib Combination Therapy of Relapsed and Refractory Acute Lymphoblastic Leukemia in Children
Klinicheskaya Onkogematologiya/Clinical Oncohematology
Oncology
Hematology
Pcn170 - Cost-Effectiveness of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: A Canadian Societal Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Correlates of Resistance and Relapse During Blinatumomab Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia
American Journal of Hematology
Hematology
